Guided Therapeutics P/E

Mi az Guided Therapeutics P/E?

A P/E az Guided Therapeutics, Inc. - N/A

Mi a P/E meghatározása?



Ár / nyereség arány a vállalat részvényárfolyamának aránya a társaság egy részvényre jutó nyereségével, amelyet tizenkét hónap alatt számítottak ki.

The price to earnings ratio is the most widely used method for determining whether shares are accurately valued in relation to one another. But the P/E ratio does not in itself indicate whether the share is a bargain. The P/E ratio depends on the market’s perception of the risk and future growth in earnings. A company with a low P/E ratio indicates that the market perceives it as a higher risk or a lower growth or both as compared to a company with a higher price to earnings ratio. The P/E ratio of a listed company’s stock is the result of the collective perception of the market as to how risky the company is and what its earnings growth prospects are in relation to that of other companies. Investors use the P/E ratio to compare their own perception of the risk and growth of a company against the market’s collective perception of the risk and growth as reflected in the current P/E ratio.

P/E a Health Care szektor a OTC-on cégekben a Guided Therapeutics -hoz képest

Mit csinál Guided Therapeutics?

Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.

p/e -hoz hasonló cégek Guided Therapeutics